J Prados
Overview
Explore the profile of J Prados including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mesas C, Martinez R, Doello K, Ortiz R, Lopez-Jurado M, Bermudez F, et al.
Biomed Pharmacother
. 2022 Jun;
149:112883.
PMID: 35692123
Euphorbia lathyris seeds have been used to treat various medical conditions. We previously reported that ethanolic extract from the defatted seed of Euphorbia lathyris (EE) (variety S3201) possesses a potent...
2.
Telley L, Agirman G, Prados J, Amberg N, Fievre S, Oberst P, et al.
Science
. 2019 May;
364(6440).
PMID: 31073041
During corticogenesis, distinct subtypes of neurons are sequentially born from ventricular zone progenitors. How these cells are molecularly temporally patterned is poorly understood. We used single-cell RNA sequencing at high...
3.
Hasler R, Preti M, Meskaldji D, Prados J, Adouan W, Rodriguez C, et al.
Psychiatry Res Neuroimaging
. 2017 Sep;
269:54-61.
PMID: 28938222
Attention deficit hyperactivity disorder (ADHD) is accompanied by resting-state alterations, including abnormal activity, connectivity and asymmetry of the default-mode network (DMN). Concurrently, recent studies suggested a link between ADHD and...
4.
Rama A, Aguilera A, Melguizo C, Caba O, Prados J
Dis Markers
. 2015 Dec;
2015:390161.
PMID: 26648599
Colorectal carcinoma is the third most prevalent cancer in the world. In the most advanced stages, the use of chemotherapy induces a poor response and is usually accompanied by other...
5.
Martin-Banderas L, Munoz-Rubio I, Prados J, Alvarez-Fuentes J, Calderon-Montano J, Lopez-Lazaro M, et al.
Int J Pharm
. 2015 Apr;
487(1-2):205-12.
PMID: 25899283
Nanoplatforms can optimize the efficacy and safety of chemotherapy, and thus cancer therapy. However, new approaches are encouraged in developing new nanomedicines against malignant cells. In this work, a reproducible...
6.
Prados J, Stenz L, Courtet P, Prada P, Nicastro R, Adouan W, et al.
Genes Brain Behav
. 2015 Jan;
14(2):177-88.
PMID: 25612291
Early life adversity plays a critical role in the emergence of borderline personality disorder (BPD) and this could occur through epigenetic programming. In this perspective, we aimed to determine whether...
7.
Alvarez P, Carrillo E, Velez C, Hita-Contreras F, Martinez-Amat A, Rodriguez-Serrano F, et al.
Biomed Res Int
. 2013 Jul;
2013:312656.
PMID: 23844360
Regulation of hematopoietic stem cell release, migration, and homing from the bone marrow (BM) and of the mobilization pathway involves a complex interaction among adhesion molecules, cytokines, proteolytic enzymes, stromal...
8.
Prados J, Melguizo C, Ortiz R, Perazzoli G, Cabeza L, Alvarez P, et al.
Anticancer Agents Med Chem
. 2013 Apr;
13(8):1204-16.
PMID: 23574385
The number of patients with colorectal cancer, the third most frequently diagnosed malignancy in the world, has increased markedly over the past 20 years and will continue to increase in...
9.
Granger K, Prados J, Young A
Behav Brain Res
. 2012 May;
233(1):201-8.
PMID: 22579971
Deficits in selective attention are seen in positively symptomatic schizophrenia sufferers, and in normal people displaying schizotypal traits. We investigated the relationship between selective attention and schizotypy in undergraduate students,...
10.
Prados J, Alvarez P, Melguizo C, Rodriguez-Serrano F, Carrillo E, Boulaiz H, et al.
Curr Med Chem
. 2012 Mar;
19(12):1870-88.
PMID: 22414080
Despite advances in cancer treatment, a large number of patients eventually develop metastatic disease that is generally incurable. Systemic chemotherapy remains the standard treatment for these patients. Several chemotherapeutic combinations...